At 7.2x earnings and a $676M market cap, TBLD screens optically cheap, but this is not a clean deep value setup. The absence of a Forward P/E and Altman Z-Score eliminates forward visibility on both growth and balance sheet safety, and the Piotroski F-Score of 2 is a glaring red flag that fundamentally weakens the value thesis. With Price/Sales at 6.9 and Price/Book at 1, the market is not pricing in distress, yet it is clearly discounting quality—this is statistically cheap on trailing earnings but fundamentally fragile based on the limited health metrics provided. Without forward estimates or solvency indicators, this is a low-multiple name lacking confirmation of durability.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.